- Home
- OBT vs TRDA Comparison
OBT vs TRDA Comparison
Compare OBT & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- TRDA
- Stock Information
- Founded
- OBT 1892
- TRDA 2016
- Country
- OBT United States
- TRDA United States
- Employees
- OBT N/A
- TRDA 183
- Industry
- OBT Major Banks
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- TRDA Health Care
- Exchange
- OBT Nasdaq
- TRDA Nasdaq
- Market Cap
- OBT 294.2M
- TRDA 264.5M
- IPO Year
- OBT N/A
- TRDA 2021
- Fundamental
- Price
- OBT $27.77
- TRDA $6.71
- Analyst Decision
- OBT Buy
- TRDA Strong Buy
- Analyst Count
- OBT 1
- TRDA 3
- Target Price
- OBT $35.50
- TRDA $25.67
- AVG Volume (30 Days)
- OBT 106.2K
- TRDA 144.8K
- Earning Date
- OBT 07-30-2025
- TRDA 08-12-2025
- Dividend Yield
- OBT 1.89%
- TRDA N/A
- EPS Growth
- OBT N/A
- TRDA N/A
- EPS
- OBT 2.41
- TRDA 0.61
- Revenue
- OBT $100,883,000.00
- TRDA $172,220,000.00
- Revenue This Year
- OBT $18.39
- TRDA N/A
- Revenue Next Year
- OBT $7.98
- TRDA N/A
- P/E Ratio
- OBT $11.42
- TRDA $10.77
- Revenue Growth
- OBT N/A
- TRDA 5.74
- 52 Week Low
- OBT $20.97
- TRDA $6.49
- 52 Week High
- OBT $33.06
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- OBT 68.20
- TRDA 49.92
- Support Level
- OBT $26.67
- TRDA $6.87
- Resistance Level
- OBT $27.86
- TRDA $7.62
- Average True Range (ATR)
- OBT 0.96
- TRDA 0.30
- MACD
- OBT 0.31
- TRDA 0.08
- Stochastic Oscillator
- OBT 89.59
- TRDA 82.04
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.